| WXS | Name: | 4-methyl-5-{[(9H-purin-6-yl)sulfanyl]methyl}-2H-1,3-dioxol-2-one | Formula: | C10 H8 N4 O3 S | SMILES: | c2(c1c(ncn1)ncn2)SCC3=C(C)OC(=O)O3 | InChi: | InChI=1S/C10H8N4O3S/c1-5-6(17-10(15)16-5)2-18-9-7-8(12-3-11-7)13-4-14-9/h3-4H,2H2,1H3,(H,11,12,13,14) | Definition date: | 2020-11-17 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | 4-methyl-5-{[(9H-purin-6-yl)sulfanyl]methyl}-2H-1,3-dioxol-2-one |
|
| WXY | Name: | (1-azaspiro[4.5]decan-1-yl)(7H-pyrrolo[2,3-d]pyrimidin-4-yl)methanone | Formula: | C16 H20 N4 O | SMILES: | C4CCC3(CCCN3C(c2c1c(ncc1)ncn2)=O)CC4 | InChi: | InChI=1S/C16H20N4O/c21-15(13-12-5-9-17-14(12)19-11-18-13)20-10-4-8-16(20)6-2-1-3-7-16/h5,9,11H,1-4,6-8,10H2,(H,17,18,19) | Definition date: | 2020-11-17 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | (1-azaspiro[4.5]decan-1-yl)(7H-pyrrolo[2,3-d]pyrimidin-4-yl)methanone |
|
| WY7 | Name: | 3-{[5-(furan-2-yl)-1,2-oxazol-3-yl]methyl}-3H-purin-6-amine | Formula: | C13 H10 N6 O2 | SMILES: | c4(CN2C=NC(=C1N=CN=C12)N)cc(c3ccco3)on4 | InChi: | InChI=1S/C13H10N6O2/c14-12-11-13(16-6-15-11)19(7-17-12)5-8-4-10(21-18-8)9-2-1-3-20-9/h1-4,6-7H,5,14H2 | Definition date: | 2020-11-17 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | 3-{[5-(furan-2-yl)-1,2-oxazol-3-yl]methyl}-3H-purin-6-amine |
|
| WYA | Name: | 3-{[methyl(pyrido[2,3-b]pyrazin-6-yl)amino]methyl}[1,2,4]triazolo[4,3-a]pyrazin-8(7H)-one | Formula: | C14 H12 N8 O | SMILES: | c3c(N(C)Cc1n2c(nn1)C(=O)NC=C2)nc4c(c3)nccn4 | InChi: | InChI=1S/C14H12N8O/c1-21(10-3-2-9-12(18-10)16-5-4-15-9)8-11-19-20-13-14(23)17-6-7-22(11)13/h2-7H,8H2,1H3,(H,17,23) | Definition date: | 2020-11-17 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | 3-{[methyl(pyrido[2,3-b]pyrazin-6-yl)amino]methyl}[1,2,4]triazolo[4,3-a]pyrazin-8(7H)-one |
|
| WYG | Name: | [(2R)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)morpholin-2-yl]acetic acid | Formula: | C12 H14 N4 O3 | SMILES: | c3cc2c(N1CC(CC(=O)O)OCC1)ncnc2n3 | InChi: | InChI=1S/C12H14N4O3/c17-10(18)5-8-6-16(3-4-19-8)12-9-1-2-13-11(9)14-7-15-12/h1-2,7-8H,3-6H2,(H,17,18)(H,13,14,15)/t8-/m1/s1 | Definition date: | 2020-11-17 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | [(2R)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)morpholin-2-yl]acetic acid |
|
| WYJ | Name: | [(2S,6R)-6-methyl-4-(9H-pyrimido[4,5-b]indol-4-yl)morpholin-2-yl]methanol | Formula: | C16 H18 N4 O2 | SMILES: | c4cc2c(c1c(ncnc1n2)N3CC(C)OC(CO)C3)cc4 | InChi: | InChI=1S/C16H18N4O2/c1-10-6-20(7-11(8-21)22-10)16-14-12-4-2-3-5-13(12)19-15(14)17-9-18-16/h2-5,9-11,21H,6-8H2,1H3,(H,17,18,19)/t10-,11+/m1/s1 | Definition date: | 2020-11-17 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | [(2S,6R)-6-methyl-4-(9H-pyrimido[4,5-b]indol-4-yl)morpholin-2-yl]methanol |
|
| WYY | Name: | 3-[(3S)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]propanoic acid | Formula: | C14 H18 N4 O2 | SMILES: | c13c(ncnc1N2CCCC(CCC(O)=O)C2)ncc3 | InChi: | InChI=1S/C14H18N4O2/c19-12(20)4-3-10-2-1-7-18(8-10)14-11-5-6-15-13(11)16-9-17-14/h5-6,9-10H,1-4,7-8H2,(H,19,20)(H,15,16,17)/t10-/m0/s1 | Definition date: | 2020-11-18 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | 3-[(3S)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]propanoic acid |
|
| RVO | Name: | 5-chloro-6-{(3R)-3-[(pyridin-4-yl)oxy]pyrrolidin-1-yl}pyrimidin-4-amine | Formula: | C13 H14 Cl N5 O | SMILES: | Clc1c(ncnc1N)N1CCC(C1)Oc1ccncc1 | InChi: | InChI=1S/C13H14ClN5O/c14-11-12(15)17-8-18-13(11)19-6-3-10(7-19)20-9-1-4-16-5-2-9/h1-2,4-5,8,10H,3,6-7H2,(H2,15,17,18)/t10-/m1/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | 5-chloro-6-{(3R)-3-[(pyridin-4-yl)oxy]pyrrolidin-1-yl}pyrimidin-4-amine |
|
| RVS | Name: | (1S,2S)-1-[4-(cyclopropylcarbamamido)benzamido]-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid | Formula: | C22 H23 N3 O4 | SMILES: | O=C(NC1CC1)Nc1ccc(cc1)C(=O)NC1c2ccccc2CCC1C(=O)O | InChi: | InChI=1S/C22H23N3O4/c26-20(14-5-8-15(9-6-14)23-22(29)24-16-10-11-16)25-19-17-4-2-1-3-13(17)7-12-18(19)21(27)28/h1-6,8-9,16,18-19H,7,10-12H2,(H,25,26)(H,27,28)(H2,23,24,29)/t18-,19+/m0/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | (1S,2S)-1-[4-(cyclopropylcarbamamido)benzamido]-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid |
|
| RW5 | Name: | [(2S,4S)-4-methyl-2-(5-methylfuran-2-yl)piperidin-1-yl](7H-pyrrolo[2,3-d]pyrimidin-4-yl)methanone | Formula: | C18 H20 N4 O2 | SMILES: | CC1CCN(C(C1)c1ccc(C)o1)C(=O)c1ncnc2[NH]ccc21 | InChi: | InChI=1S/C18H20N4O2/c1-11-6-8-22(14(9-11)15-4-3-12(2)24-15)18(23)16-13-5-7-19-17(13)21-10-20-16/h3-5,7,10-11,14H,6,8-9H2,1-2H3,(H,19,20,21)/t11-,14-/m0/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | [(2S,4S)-4-methyl-2-(5-methylfuran-2-yl)piperidin-1-yl](7H-pyrrolo[2,3-d]pyrimidin-4-yl)methanone |
|
| RWC | Name: | (3S)-1-[4-(cyclopropylcarbamamido)benzoyl]-1,2,3,4-tetrahydroquinoline-3-carboxylic acid | Formula: | C21 H21 N3 O4 | SMILES: | O=C(NC1CC1)Nc1ccc(cc1)C(=O)N1CC(Cc2ccccc21)C(=O)O | InChi: | InChI=1S/C21H21N3O4/c25-19(13-5-7-16(8-6-13)22-21(28)23-17-9-10-17)24-12-15(20(26)27)11-14-3-1-2-4-18(14)24/h1-8,15,17H,9-12H2,(H,26,27)(H2,22,23,28)/t15-/m0/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | (3S)-1-[4-(cyclopropylcarbamamido)benzoyl]-1,2,3,4-tetrahydroquinoline-3-carboxylic acid |
|
| RWQ | Name: | [(3R)-1-(7-fluoro-9H-pyrimido[4,5-b]indol-4-yl)piperidin-3-yl]methanol | Formula: | C16 H17 F N4 O | SMILES: | Fc1ccc2c3c(ncnc3[NH]c2c1)N1CCCC(CO)C1 | InChi: | InChI=1S/C16H17FN4O/c17-11-3-4-12-13(6-11)20-15-14(12)16(19-9-18-15)21-5-1-2-10(7-21)8-22/h3-4,6,9-10,22H,1-2,5,7-8H2,(H,18,19,20)/t10-/m1/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | [(3R)-1-(7-fluoro-9H-pyrimido[4,5-b]indol-4-yl)piperidin-3-yl]methanol |
|
| RXX | Name: | 9-{[(2P)-2-(5-methylfuran-2-yl)-1,3-thiazol-4-yl]methyl}-9H-purine-2,6-diamine | Formula: | C14 H13 N7 O S | SMILES: | Nc1nc(N)nc2c1ncn2Cc1csc(n1)c1oc(C)cc1 | InChi: | InChI=1S/C14H13N7OS/c1-7-2-3-9(22-7)13-18-8(5-23-13)4-21-6-17-10-11(15)19-14(16)20-12(10)21/h2-3,5-6H,4H2,1H3,(H4,15,16,19,20) | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | 9-{[(2P)-2-(5-methylfuran-2-yl)-1,3-thiazol-4-yl]methyl}-9H-purine-2,6-diamine |
|
| RY6 | Name: | (1S,2S)-1-(4-carbamamidobenzamido)-4-hydroxy-2,3-dihydro-1H-indene-2-carboxylic acid | Formula: | C18 H17 N3 O5 | SMILES: | NC(=O)Nc1ccc(cc1)C(=O)NC1c2cccc(O)c2CC1C(=O)O | InChi: | InChI=1S/C18H17N3O5/c19-18(26)20-10-6-4-9(5-7-10)16(23)21-15-11-2-1-3-14(22)12(11)8-13(15)17(24)25/h1-7,13,15,22H,8H2,(H,21,23)(H,24,25)(H3,19,20,26)/t13-,15+/m0/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | (1S,2S)-1-(4-carbamamidobenzamido)-4-hydroxy-2,3-dihydro-1H-indene-2-carboxylic acid |
|
| RYC | Name: | (1R,2R)-1-(4-carbamamidobenzamido)-4-hydroxy-2,3-dihydro-1H-indene-2-carboxylic acid | Formula: | C18 H17 N3 O5 | SMILES: | NC(=O)Nc1ccc(cc1)C(=O)NC1c2cccc(O)c2CC1C(=O)O | InChi: | InChI=1S/C18H17N3O5/c19-18(26)20-10-6-4-9(5-7-10)16(23)21-15-11-2-1-3-14(22)12(11)8-13(15)17(24)25/h1-7,13,15,22H,8H2,(H,21,23)(H,24,25)(H3,19,20,26)/t13-,15+/m1/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | (1R,2R)-1-(4-carbamamidobenzamido)-4-hydroxy-2,3-dihydro-1H-indene-2-carboxylic acid |
|
| RYI | Name: | (5R)-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2lambda~6~-thia-7-azaspiro[4.5]decane-2,2-dione | Formula: | C14 H18 N4 O2 S | SMILES: | O=S1(=O)CCC2(CCCN(C2)c2ncnc3[NH]ccc32)C1 | InChi: | InChI=1S/C14H18N4O2S/c19-21(20)7-4-14(9-21)3-1-6-18(8-14)13-11-2-5-15-12(11)16-10-17-13/h2,5,10H,1,3-4,6-9H2,(H,15,16,17)/t14-/m1/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | (5R)-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2lambda~6~-thia-7-azaspiro[4.5]decane-2,2-dione |
|
| RZ9 | Name: | 5-[(3S)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-1,3,4-oxadiazol-2(3H)-one | Formula: | C13 H14 N6 O2 | SMILES: | O=C1NN=C(O1)C1CN(CCC1)c1ncnc2[NH]ccc21 | InChi: | InChI=1S/C13H14N6O2/c20-13-18-17-12(21-13)8-2-1-5-19(6-8)11-9-3-4-14-10(9)15-7-16-11/h3-4,7-8H,1-2,5-6H2,(H,18,20)(H,14,15,16)/t8-/m0/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | 5-[(3S)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-1,3,4-oxadiazol-2(3H)-one |
|
| RZR | Name: | (1R,2S)-1-[4-(methylcarbamamido)benzamido]-2,3-dihydro-1H-indene-2-carboxylic acid | Formula: | C19 H19 N3 O4 | SMILES: | CNC(=O)Nc1ccc(cc1)C(=O)NC1c2ccccc2CC1C(=O)O | InChi: | InChI=1S/C19H19N3O4/c1-20-19(26)21-13-8-6-11(7-9-13)17(23)22-16-14-5-3-2-4-12(14)10-15(16)18(24)25/h2-9,15-16H,10H2,1H3,(H,22,23)(H,24,25)(H2,20,21,26)/t15-,16-/m0/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | (1R,2S)-1-[4-(methylcarbamamido)benzamido]-2,3-dihydro-1H-indene-2-carboxylic acid |
|
| S09 | Name: | (1R,2R)-4-hydroxy-1-[4-(phenylcarbamamido)benzamido]-2,3-dihydro-1H-indene-2-carboxylic acid | Formula: | C24 H21 N3 O5 | SMILES: | O=C(Nc1ccccc1)Nc1ccc(cc1)C(=O)NC1c2cccc(O)c2CC1C(=O)O | InChi: | InChI=1S/C24H21N3O5/c28-20-8-4-7-17-18(20)13-19(23(30)31)21(17)27-22(29)14-9-11-16(12-10-14)26-24(32)25-15-5-2-1-3-6-15/h1-12,19,21,28H,13H2,(H,27,29)(H,30,31)(H2,25,26,32)/t19-,21+/m1/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | (1R,2R)-4-hydroxy-1-[4-(phenylcarbamamido)benzamido]-2,3-dihydro-1H-indene-2-carboxylic acid |
|
| S0T | Name: | (1S,2S)-4-hydroxy-1-[4-(phenylcarbamamido)benzamido]-2,3-dihydro-1H-indene-2-carboxylic acid | Formula: | C24 H21 N3 O5 | SMILES: | O=C(Nc1ccccc1)Nc1ccc(cc1)C(=O)NC1c2cccc(O)c2CC1C(=O)O | InChi: | InChI=1S/C24H21N3O5/c28-20-8-4-7-17-18(20)13-19(23(30)31)21(17)27-22(29)14-9-11-16(12-10-14)26-24(32)25-15-5-2-1-3-6-15/h1-12,19,21,28H,13H2,(H,27,29)(H,30,31)(H2,25,26,32)/t19-,21+/m0/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | (1S,2S)-4-hydroxy-1-[4-(phenylcarbamamido)benzamido]-2,3-dihydro-1H-indene-2-carboxylic acid |
|
| S1F | Name: | (1S,2S)-1-{4-[(methoxycarbonyl)amino]benzamido}-2,3-dihydro-1H-indene-2-carboxylic acid | Formula: | C19 H18 N2 O5 | SMILES: | O=C(OC)Nc1ccc(cc1)C(=O)NC1c2ccccc2CC1C(=O)O | InChi: | InChI=1S/C19H18N2O5/c1-26-19(25)20-13-8-6-11(7-9-13)17(22)21-16-14-5-3-2-4-12(14)10-15(16)18(23)24/h2-9,15-16H,10H2,1H3,(H,20,25)(H,21,22)(H,23,24)/t15-,16+/m0/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | (1S,2S)-1-{4-[(methoxycarbonyl)amino]benzamido}-2,3-dihydro-1H-indene-2-carboxylic acid |
|
| S1O | Name: | {1-[(3S)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-1H-1,2,3-triazol-4-yl}methanol | Formula: | C14 H17 N7 O | SMILES: | OCc1cn(nn1)C1CN(CCC1)c1ncnc2[NH]ccc21 | InChi: | InChI=1S/C14H17N7O/c22-8-10-6-21(19-18-10)11-2-1-5-20(7-11)14-12-3-4-15-13(12)16-9-17-14/h3-4,6,9,11,22H,1-2,5,7-8H2,(H,15,16,17)/t11-/m0/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | {1-[(3S)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-1H-1,2,3-triazol-4-yl}methanol |
|
| S1X | Name: | (1S,2S)-1-{4-[(cyclopropanecarbonyl)amino]benzamido}-2,3-dihydro-1H-indene-2-carboxylic acid | Formula: | C21 H20 N2 O4 | SMILES: | O=C(Nc1ccc(cc1)C(=O)NC1c2ccccc2CC1C(=O)O)C1CC1 | InChi: | InChI=1S/C21H20N2O4/c24-19(12-5-6-12)22-15-9-7-13(8-10-15)20(25)23-18-16-4-2-1-3-14(16)11-17(18)21(26)27/h1-4,7-10,12,17-18H,5-6,11H2,(H,22,24)(H,23,25)(H,26,27)/t17-,18+/m0/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | (1S,2S)-1-{4-[(cyclopropanecarbonyl)amino]benzamido}-2,3-dihydro-1H-indene-2-carboxylic acid |
|
| S2R | Name: | (1R,2R)-1-{4-[(cyclopropanecarbonyl)amino]benzamido}-2,3-dihydro-1H-indene-2-carboxylic acid | Formula: | C21 H20 N2 O4 | SMILES: | O=C(Nc1ccc(cc1)C(=O)NC1c2ccccc2CC1C(=O)O)C1CC1 | InChi: | InChI=1S/C21H20N2O4/c24-19(12-5-6-12)22-15-9-7-13(8-10-15)20(25)23-18-16-4-2-1-3-14(16)11-17(18)21(26)27/h1-4,7-10,12,17-18H,5-6,11H2,(H,22,24)(H,23,25)(H,26,27)/t17-,18+/m1/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | (1R,2R)-1-{4-[(cyclopropanecarbonyl)amino]benzamido}-2,3-dihydro-1H-indene-2-carboxylic acid |
|
| S3E | Name: | [(2S)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)morpholin-2-yl]acetic acid | Formula: | C12 H14 N4 O3 | SMILES: | O=C(O)CC1CN(CCO1)c1ncnc2[NH]ccc12 | InChi: | InChI=1S/C12H14N4O3/c17-10(18)5-8-6-16(3-4-19-8)12-9-1-2-13-11(9)14-7-15-12/h1-2,7-8H,3-6H2,(H,17,18)(H,13,14,15)/t8-/m0/s1 | Definition date: | 2022-06-23 | Last modified: | 2022-07-08 | Release date: | 2022-07-13 | Identifier: | [(2S)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)morpholin-2-yl]acetic acid |
|